BOM (drug)
Pharmaceutical compound
From Wikipedia, the free encyclopedia
BOM, also known as 3,4,5,β-tetramethoxyphenethylamine or as β-methoxymescaline, is a psychoactive drug of the phenethylamine, scaline, and BOx families related to mescaline.[1] It is the β-methoxy derivative of mescaline.[1]
- None
| |
 | |
| Clinical data | |
|---|---|
| Other names | 3,4,5,β-Tetramethoxyphenethylamine; β-Methoxymescaline; β-MeO-mescaline; β-MeO-3,4,5-TMPEA; β-Methoxy-3,4,5-TMPEA; β-MeO-TMPEA |
| Routes of administration | Oral[1] |
| Drug class | Psychoactive drug |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H19NO4 |
| Molar mass | 241.287 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Use and effects
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists BOM's dose as greater than 200 mg orally and its duration as unknown.[1] Some indications of threshold central effects were observed at doses of 120 and 180 mg orally, but higher doses were not explored.[1] BOx drugs are known to be less potent than their non-β-substituted counterparts, so BOM might be active in the range of 200 to 400 mg orally according to Shulgin, but this remains unknown.[1]
Chemistry
History
BOM was briefly mentioned by Abram Hoffer and Humphrey Osmond in their 1967 book The Hallucinogens.[5] Subsequently, it was described in greater detail by Alexander Shulgin, Peyton Jacob III, and Darrell Lemaire in 1985.[6] In addition, it was described in further detail by Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved).[1]
Society and culture
Legal status
Canada
BOM is not a controlled substance in Canada as of 2025.[7]
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[8]